ACADIA PHARMACEUTICALS INC (ACAD)
ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.
Address
12830 EL CAMINO REAL
SAN DIEGO, CA 92130
Founded
1993
Number of Employees
598
Website
http://www.acadia.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)